The efficacy and safety comparison of docetaxel, cabazitaxel, estramustine, and mitoxantrone for castration-resistant prostate cancer: A network meta-analysis-Reference-Cited by-同舟云学术

The efficacy and safety comparison of docetaxel, cabazitaxel, estramustine, and mitoxantrone for castration-resistant prostate cancer: A network meta-analysis

Published:2018-08 Issue: Volume:56 Page:133-140
ISSN:1743-9191
Container-title:International Journal of Surgery
language:en
Short-container-title:International Journal of Surgery

Author:

Song Pan^ORCID,Huang Chuiguo^ORCID,Wang Yan

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference55 articles.

1. CA: a cancer journal for clinicians;Siegel;2017,2017

2. CA: a cancer journal for clinicians;Siegel;2018,2018

3. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013;Heidenreich;Eur. Urol.,2014

4. Management of patients with advanced prostate cancer: recommendations of the st gallen advanced prostate cancer consensus conference (APCCC) 2015;Gillessen;Ann. Oncol.: Official Journal of the European Society for Medical Oncology,2015

5. Characterising the castration-resistant prostate cancer population: a systematic review;Kirby;Int. J. Clin. Pract.,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Observation of Serological Index and Efficacy of Abiraterone Hydrochloride Tablets Combined with Endocrine Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer;Archivos Españoles de Urología;2023

2. Development of a Plasmonic Sensor for a Chemotherapeutic Agent Cabazitaxel;ACS Omega;2022-12-26

3. 177Lu-PSMA Radioligand Therapy Is Favorable as Third-Line Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials;Biomedicines;2021-08-19

4. Prediction of Synergistic Drug Combinations for Prostate Cancer by Transcriptomic and Network Characteristics;Frontiers in Pharmacology;2021-04-12

5. Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes;PLOS ONE;2021-03-04